Chemistry & Sequence Reference
Identity fields below are based on public chemistry or biomedical reference records where available. Batch-specific purity, identity, counter-ion and analytical results should be verified against the documentation for the selected stock source.
Overview
Survodutide (BI 456906) is an acylated peptide developed as a dual glucagon-receptor and GLP-1-receptor agonist. PubChem records CAS 2805997-46-8, CID 168429725 and a molecular weight of approximately 4,232 g/mol.
Laboratory and clinical-development literature uses survodutide to study combined GCGR/GLP-1R signaling and downstream metabolic endpoints.
This product is strictly for research purposes only. Not approved for human or animal use.
Reference: NIH PubChem | PubMed
Key Characteristics
MOLECULAR PROFILE
Formula: C192H289N47O61
Weight: 4232 g/mol
CAS: 2805997-46-8
Sequence / Composition: Modified acylated peptide; see PubChem structural record
PHYSICAL PROPERTIES
Form: Lyophilized peptide powder
Solubility: Formulation-dependent; verify against batch documentation.
Stability: Modified peptide research material; protect from moisture and repeated temperature cycling.
Storage: Store lyophilized material frozen for long-term research storage; follow the batch-specific COA.







